Advances in analytical technologies for emerging drug modalities and their separation challenges in LC-MS systems
Authors:
- 2 August 2024
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1732, 465226
Abstract
No abstract availableKeywords
Funding Information
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
This publication has 132 references indexed in Scilit:
- Identification and characterization of a residual host cell protein hexosaminidase B associated with N ‐glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody productBiotechnology Progress, 2021
- An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancerCancer Medicine, 2020
- The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk‐based management for their controlBiotechnology and Bioengineering, 2015
- Current ADC Linker ChemistryPharmaceutical Research, 2015
- Impact of mobile phase temperature on recovery and stability of monoclonal antibodies using recent reversed‐phase stationary phasesJournal of Separation Science, 2012
- The use of strong anion‐exchange (SAX) magnetic particles for the extraction of therapeutic siRNA and their analysis by liquid chromatography/mass spectrometryRapid Communications in Mass Spectrometry, 2011
- Magnetic particles for the separation and purification of nucleic acidsApplied Microbiology and Biotechnology, 2006
- A modified protein precipitation procedure for efficient removal of albumin from serumElectrophoresis, 2005
- Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometryMass Spectrometry Reviews, 2002
- A Procedure for Quantitative Determination of Tris(2-Carboxyethyl)phosphine, an Odorless Reducing Agent More Stable and Effective Than DithiothreitolAnalytical Biochemistry, 1994